modified chemotherapy
Showing 1 - 25 of >10,000
Peritoneal Carcinomatosis, Appendiceal Tumors, Colorectal Cancer Metastatic Trial in Montréal (Modified early post-operative
Not yet recruiting
- Peritoneal Carcinomatosis
- +2 more
- Modified early post-operative intraperitoneal chemotherapy (mEPIC)
-
Montréal, Quebec, CanadaHôpital Maisonneuve-Rosemont
Jun 12, 2023
Gastric Cancer (Diagnosis) Trial (Modified Banxia Xiexin Decoction, combination chemo with Placebo granules)
Completed
- Gastric Cancer (Diagnosis)
- Modified Banxia Xiexin Decoction
- combination chemotherapy with Placebo granules
- (no location specified)
Jun 16, 2023
TPExtreme Induced Chemotherapy Followed by Surgery and
Recruiting
- Oral Squamous Cell Carcinoma
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Modified radical surgery
- Radical surgery
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
May 14, 2023
Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)
Not yet recruiting
- Inflammatory Breast Cancer
- Breast conserving surgery
- Radical modified mastectomy
- (no location specified)
Nov 14, 2023
Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 1, 2023
AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))
Terminated
- AIDS-related Lymphoma
- HIV Infections
- PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 4, 2022
Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)
Recruiting
- Mucinous Ovarian Cancer
- +2 more
- Bevacizumab + modified FOLFIRINOX
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Dec 25, 2022
Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human
Recruiting
- Optic Glioma
- Pediatric Brain Tumor, Optic Nerve Glioma
- Carboplatin
- +2 more
-
Beijing, ChinaCapital Medical University Sanbo Brain Hospital
Jul 4, 2022
Locally Advanced Gastric Cancer Trial in Beijing (Paclitaxel/DDP, XELOX/SOX)
Recruiting
- Locally Advanced Gastric Cancer
-
Beijing, Beijing, ChinaDepartment of Medical Oncology, Peking Union Medical College Hos
Feb 23, 2021
Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)
Active, not recruiting
- Breast Cancer
- +3 more
- Talimogene laherparepvec
- Paclitaxel
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022
Resectable Pancreatic Adenocarcinoma Trial in Seoul (neoadjuvant modified FOLFIRINOX)
Recruiting
- Resectable Pancreatic Adenocarcinoma
- neoadjuvant modified FOLFIRINOX
-
Seoul, Korea, Republic ofDivision of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
Sep 23, 2021
Neuroblastoma Trial in Houston (SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP, SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2
Active, not recruiting
- Neuroblastoma
- SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP
- SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2 SKNLP
-
Houston, TexasTexas Children's Hospital
Mar 3, 2022
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic
Recruiting
- Mesothelioma
- Solitary Fibrous Tumor of the Pleura
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 13, 2021
Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)
Active, not recruiting
- Acute Lymphocytic Leukemia
- Lymphoma
- Biological/Genetically Modified T cells
- Cyclophosphamide-based chemotherapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)
Active, not recruiting
- Metastatic Colorectal Cancer
- mFOLFOX6
- +3 more
-
Duarte, California
- +6 more
Jan 18, 2023
Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)
Active, not recruiting
- Advanced Solid Tumors
- +3 more
- CAN04 (nadunolimab)
- +3 more
-
Saint-Herblain, Boulevard Jacques Monod, France
- +5 more
Oct 20, 2022
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in
Active, not recruiting
- Adenocarcinoma of the Esophagus
- +5 more
- oxaliplatin
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022
Colorectal Cancer Trial in Paris (FOLFOX regimen, fluorouracil, leucovorin calcium)
Active, not recruiting
- Colorectal Cancer
- FOLFOX regimen
- +5 more
-
Paris, FranceGERCOR Groupe Cooperateur Multidisciplinaire en Oncologie
Jan 20, 2022
Brain Tumor Adult Trial in Birmingham (DRI cell therapy)
Recruiting
- Brain Tumor Adult
- DRI cell therapy
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Feb 1, 2022
Relapsed B-Cell Acute Lymphoblastic Leukemia Trial in Boston, New York (procedure, drug, biological)
Active, not recruiting
- Relapsed B-Cell Acute Lymphoblastic Leukemia
- leukapheresis or collection of PBMCs
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2022
Hodgkin Lymphoma Trial in Chengdu, Nanjing, Shanghai (Combined chemo with or without involved-field radiotherapy)
Recruiting
- Hodgkin Lymphoma
- Combined chemotherapy with or without involved-field radiotherapy
-
Chengdu, China
- +2 more
Mar 17, 2022
Gastric Cancer, Chemo Effect, Elderly Patients Trial (Chemotherapy, Curative gastrectomy)
Not yet recruiting
- Gastric Cancer
- +3 more
- Chemotherapy
- Curative gastrectomy
- (no location specified)
Dec 17, 2020
Pancreatic Adenocarcinoma Trial (Nab paclitaxel, Gemcitabine, mFOLFIRINOX)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Nab paclitaxel
- +2 more
- (no location specified)
Apr 6, 2021
Hematologic Tumors Trial run by the NCI (Stem cell transplantation, Fludarabine, Cyclophosphamide)
Completed
- Hematologic Neoplasms
- Stem cell transplantation
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 19, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- oxaliplatin
- +5 more
-
Fairfield, Connecticut
- +8 more
Oct 31, 2022